Unravelling the risk of (intermediate) antitrypsin deficiency
- PMID: 33268455
- DOI: 10.1136/thoraxjnl-2020-215693
Unravelling the risk of (intermediate) antitrypsin deficiency
Keywords: Alpha1 antitrypsin deficiency; emphysema.
Conflict of interest statement
Competing interests: AMT has received research grants from CSL Behring (current) and Grifols (within the last 5 years) and consulting fees from CSL. RM has received consulting fees for educational activities and advisory boards between 2016 and 2020 sponsored by CSL Behring and Kamada.
Comment on
-
SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ.Thorax. 2021 Mar;76(3):298-301. doi: 10.1136/thoraxjnl-2020-215250. Epub 2020 Sep 11. Thorax. 2021. PMID: 32917839
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical